V Wealth Management LLC lowered its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 30.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,237 shares of the healthcare conglomerate’s stock after selling 993 shares during the quarter. V Wealth Management LLC’s holdings in UnitedHealth Group were worth $503,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Blue Chip Partners Inc. acquired a new position in shares of UnitedHealth Group during the second quarter valued at about $110,000. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group during the second quarter valued at about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its holdings in shares of UnitedHealth Group by 433.3% during the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group during the second quarter valued at about $121,000. Finally, Acrospire Investment Management LLC raised its holdings in shares of UnitedHealth Group by 130.7% during the second quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock valued at $131,000 after purchasing an additional 400 shares during the period. Hedge funds and other institutional investors own 85.65% of the company’s stock.
In other news, CEO Larry C. Renfro sold 22,598 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the transaction, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at approximately $43,310,879.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michele J. Hooper sold 5,000 shares of the stock in a transaction that occurred on Monday, December 4th. The shares were sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the transaction, the director now directly owns 36,989 shares of the company’s stock, valued at $8,218,955.80. The disclosure for this sale can be found here. In the last quarter, insiders sold 53,396 shares of company stock valued at $12,262,067. Company insiders own 0.89% of the company’s stock.
Several equities analysts have recently weighed in on the stock. Citigroup upped their price objective on shares of UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Oppenheimer upped their price objective on shares of UnitedHealth Group from $215.00 to $225.00 and gave the company an “outperform” rating in a report on Wednesday, November 29th. Cantor Fitzgerald reiterated a “buy” rating and set a $235.00 price objective on shares of UnitedHealth Group in a report on Tuesday, January 16th. Raymond James Financial reiterated a “buy” rating on shares of UnitedHealth Group in a report on Wednesday, December 6th. Finally, Deutsche Bank upped their price objective on shares of UnitedHealth Group to $260.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Two analysts have rated the stock with a hold rating and twenty-six have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $243.22.
Shares of UnitedHealth Group Inc (NYSE:UNH) opened at $230.16 on Friday. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market cap of $222,720.00, a PE ratio of 24.23, a price-to-earnings-growth ratio of 1.31 and a beta of 0.70. UnitedHealth Group Inc has a one year low of $161.74 and a one year high of $250.79.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the business posted $2.11 EPS. equities research analysts forecast that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be paid a $0.75 dividend. The ex-dividend date is Thursday, March 8th. This represents a $3.00 annualized dividend and a yield of 1.30%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.58%.
TRADEMARK VIOLATION WARNING: “UnitedHealth Group Inc (UNH) Shares Sold by V Wealth Management LLC” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/24/unitedhealth-group-inc-unh-shares-sold-by-v-wealth-management-llc.html.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.